CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...